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Background: Research suggests that dietary composition influences gastrointestinal function and bacteria-derived
metabolic products in the dog colon. We previously reported that dietary composition impacts upon the faecal
microbiota of healthy dogs. This study aims at evaluating the dietary influences on bacteria-derived metabolic
products associated with the changes in faecal microbiota that we had previously reported. We fed high-
carbohydrate starch based (HCS), [crude protein: 194 g/kg, starch: 438 g/kg], high-protein greaves-meal (HPGM),
[crude protein: 609 g/kg, starch: 54 g/kg] and dry commercial (DC), [crude protein: 264 g/kg, starch: 277 g/kg] diets,
and studied their effects on the metabolism of the colonic microbiota and faecal calprotectin concentrations in five
Beagle dogs, allocated according to the Graeco-Latin square design. Each dietary period lasted for three weeks and
was crossed-over with washout periods. Food intake, body weight, and faecal consistency scores, dry matter, pH,
ammonia, volatile fatty acids (VFAs), and faecal canine calprotectin concentrations were determined.
Results: Faecal ammonia concentrations decreased with the HCS diet. All dogs fed the HPGM diet developed
diarrhoea, which led to differences in faecal consistency scores between the diets. Faecal pH was higher with the
HPGM diet. Moreover, decreases in propionic and acetic acids coupled with increases in branched-chain fatty acids
and valeric acid caused changes in faecal total VFAs in dogs on the HPGM diet. Faecal canine calprotectin
concentration was higher with the HPGM diet and correlated positively with valeric acid concentration.
Conclusions: The HPGM diet led to diarrhoea in all dogs, and there were differences in faecal VFA profiles and
faecal canine calprotectin concentrations.
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Bacterial metabolic activity in the large intestine is
influenced by the composition of the microbiota, the co-
lonic transit time of the chyme, and the intraluminal pH
[1]. It is also closely related to the optimal absorptive func-
tioning of the colon. In vitro and in vivo studies have shown
that the final products of bacterial fermentation mostly de-
pend on the chemical composition of the chyme that* Correspondence: Ingrid.Moistus@helsinki.fi
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reproduction in any medium, provided the orreaches the large intestine [2,3]. For instance, if there is a
lack of carbohydrates (e.g., wheat, maize) in the diet, the
microorganisms ferment amino acids into short-chain fatty
acids (SCFAs) and ammonia to obtain energy [4]. A suffi-
cient throughput of carbohydrate leads to a decrease in lu-
minal nitrogenous compounds and an increase in faecal
bacterial mass [5]. The chemical composition of the
digesta/chyme, the amounts of substrates, and the physical
form of the food affect the microbial fermentation [6]. The
physical form of the diet depends on the manufacturing
process of the diet. Therefore, the latter also affects the
characteristics of the microbial fermentation. Evidence fortd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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study showed that when dogs were fed canned food with
poultry and/or beef as the protein source, they had lower
total faecal VFAs, but higher levels of faecal valeric,
propionic, and branched-chain fatty acids (BCFA) than
dogs that were fed commercial dry food with poultry as the
protein source [7].
Various studies have shown that diets can impact upon
intestinal health and lead to an increased faecal water
content and/or high faecal ammonia concentrations.
Such changes are mainly due to the protein source
[4,8-11] and protein concentration [4,12,13], followed by
the carbohydrate concentration of the diet [4,14,15]. The
induction of mucosal inflammation is an important
pathogenic negative outcome of an impact that diets can
have upon intestinal health. Methods for assessing co-
lonic inflammation in humans include the histological
evaluation of colonic biopsies and the measurement of
faecal biomarkers such as calprotectin, lactoferrin, or
polymorphonuclear neutrophil elastase [16,17]. A lack of
species-specific faecal biomarkers in dogs has prompted
the use of endoscopic sampling of the intestinal mucosa
under general anaesthesia for the collection of colonic
biopsies [18]. Faecal calprotectin is a Ca2+- and Zn2+-
binding protein that is a sensitive but nonspecific bio-
marker of intestinal inflammation [19,20]. It is also a
protein that has bacteriostatic and fungistatic properties
[21,22], which protects the intestinal epithelia against infec-
tion and contributes to the innate immunity
of the host. Bacteriostatic effects of calprotectin were
found against Listeria monocytogenes, Salmonella enterica
spp. enterica serovar Typhimurium [23]. Calprotectin is
expressed mostly by neutrophils, monocytes [24] and
activated macrophages [25], but small amounts were also
found to be expressed by keratinocytes [26]. Furthermore,
calprotectin levels are increased in serum and other body
fluids of patients that suffer from rheumatoid arthritis
or from cystic fibrosis, which can be considered to be
supporting evidence for its usefulness as a marker of
inflammation [27,28] and also for the contribution it
makes to the host’s defence mechanism [29]. Recently,
a radioimmunoassay for the quantification of canine
calprotectin in serum and faeces was developed and
analytically validated [30,31].
To the best of our knowledge, experimental studies in
dogs that assess canine faecal characteristics, VFAs and
their associations with intestinal inflammatory markers
are lacking. The current study is the hitherto unreported
part of a previously published study [32], in which we in-
vestigated the effects of the above mentioned diets on
canine faecal microbiota. In that study, we found that
faecal samples from the greaves-meal diet fed, dogs
favoured growth of species of Fusobacteriales. It is im-
portant to note that Fusobacteriales are potentialpathogens for humans [33-35]. Additionally, we reported
Coriobacteriales in dog faeces: a finding that was
reported in only one other recent study [36]. The hy-
pothesis for the current study was that the high protein
greaves-meal diet influences the measured faecal param-
eters, as it was found to remarkably increase the faecal
populations belonging to the order Fusobacteriales [32].
Therefore, our aim was to study whether the effect of
dietary greaves-meal and maize starch on faecal micro-
biota can be associated with altered faecal characteris-
tics, VFAs, and canine faecal calprotectin.
Results
The HPGM diet increased the faecal consistency score
(p < 0.01) and it led to diarrhoea in all the dogs. Faecal
pH was higher for the HPGM and the HCS diets than
for the DC diet (p < 0.01). Faecal ammonia concentra-
tions were (p = 0.01) lower for the HCS diet than for ei-
ther the HPGM or the DC diet feeding periods
(Table 1).
The total VFA concentrations were lowest (p < 0.01) for
the HPGM diet. This reduction could be partly explained
by the lower concentrations of acetic acid (p < 0.01) and of
propionic acid (p < 0.01), which both accounted for the lar-
gest proportion of the VFAs measured. Although butyric
acid was somewhat lower for the HPGM diet compared to
the DC diet there was no difference between those diets
(p = 0.08). Valeric acid and the BCFA concentrations mea-
sured were higher for the HPGM diet (p < 0.01 and
p = 0.02, respectively) compared with the DC and HCS di-
ets. The faecal canine calprotectin concentrations remained
within the established reference interval [31], but were
higher for the HPGM diet (Kruskal-Wallis test, p = 0.01)
than either the HCS or the DC diet, and they correlated
positively with valeric acid (p < 0.01).
Discussion
This study investigated the influence of feeding diets
with either high dietary protein (from its greaves-meal
content) or high carbohydrate (from its high maize
starch content) on food intake, body weight, faecal
consistency scores, faecal dry matter, pH, ammonia,
VFAs, and levels of faecal canine calprotectin.
None of the three diets used in this study affected food
intake or body weight of the dogs differently.
The source and concentration of the dietary carbohy-
drate and/or protein reaching the colon can alter condi-
tions in the colon, by changing the fermentation
characteristics and the faecal microbiota [14,37,38].
Maize and greaves-meal were respectively used in the
current study as a source of carbohydrate and protein. It
is known from previous studies that maize and greaves-
meal are highly digested in the small intestine [8,39,40].
To our knowledge diets with such high maize starch or
Table 1 Analysis of body weight and faecal consistency scores, dry matter, pH and NH3 (n = 3 faecal samples for each
variable per diet period) of 5 dogs
Variable Baseline (DC) DC1 HPGM 2 HCS 3 Kruskal-Wallis
p-value
Mixed model
p-value
Body weight, kg 19.0 [18.3–19.3] A 19.78 [18.15–21.10]A 20.00 [18.60–21.65]
A
19.40 [18.80–20.85]
A
> 0.10 > 0.10
Faecal consistency score 2.5 [2.0–3.0] B 2.5 [2.0–3.0] B 4.0 [4.0–5.0] A 2.5 [2.0–3.0] B < 0.01 < 0.01
Faecal dry matter, % 32.2 [30.1–36.2] A 32.4 [30.6–35.4] A 32.2 [13.6–35.9] A 32.5 [29.8–35.7] A > 0.10 > 0.10
Faecal pH 6.9 [6.8–7.1] A,B 6.7 [6.5–7.0] B 7.5 [6.6–7.9] A 7.2 [7.0–7.5] A,B < 0.01 < 0.01
Faecal NH3, μg/g wet
faeces
1 245 [982–1 482]
A
1 079 [693–1 468] A,
B
1 191 [710–1 778] A 835 [657–1,162] B 0.03 0.01
1DC: dry commercial diet.
2HPGM: high-protein greaves-meal diet.
3HCS: high-carbohydrate starch based diet.
Values are expressed as medians and ranges [min–max]. For each variable, diets not sharing a common superscript (A, B) are significantly different at p < 0.05 and
are marked in bold.
Hang et al. BMC Veterinary Research 2013, 9:201 Page 3 of 8
http://www.biomedcentral.com/1746-6148/9/201greaves-meal concentrations have not been used previ-
ously in studies.
In our study, the HCS diet did not affect the faecal pa-
rameters any differently from the DC diet, except for
faecal pH and ammonia. Faecal pH was higher for dogs
fed the HPGM diet than when they were fed either the
HCS or the DC diets (Table 1). This finding is consistent
with those of previous studies, in which protein-rich di-
ets led to increases in faecal pH [7,9]. Faecal ammonia
was lowest when the dogs were fed the HCS diet as
expected. The ammonia fluctuations could be explained
by two mechanisms that require further investigation.
First, a sufficient carbohydrate supply to the large intes-
tine in dogs fed the HCS diet, led to a decrease in lu-
minal nitrogenous compounds as reported earlier [5].
Second, when the dogs were fed the HCS diet decreased
amounts of protein that reached the hindgut for subse-
quent fermentation. However, the forenamed mecha-
nisms are hypothetical as the amount of carbohydrates
and protein reached to the hindgut was not measured in
this study.
There was no dietary effect on faecal dry matter.
Nevertheless, the high concentration of dietary protein
of the HPGM diet used in our study led to diarrhoea in
all the dogs (Table 1). The reason for not reaching statis-
tical significance could be due to the large variation be-
tween faecal samples within the same dietary sampling
period. This in turn, could be due to the small number
of dogs (n = 5) allocated to the study. Further, substantial
variations in faecal dry matter between dogs that re-
ceived the same dietary treatment and a lack of correl-
ation between faecal moisture and faecal consistency
score has also been reported in earlier studies [41-43].
Our finding on the undesirable effects of dietary animal
proteins on faecal consistency agrees with the results of
previous studies [8-12]. Furthermore, the only previous
study used bacterial culture methods for the assessment of
dietary effects on the faecal microbiota, and it showed anincreased number of Clostridium perfringens in dogs fed
animal (poultry or beef) protein [7]. This is consistent with
an increased number of C. perfringens colonies and de-
creased counts of Bifidobacterium organisms reported in
dogs that were fed a low-quality protein diet [8]. In our pre-
vious study, the faecal samples obtained from dogs fed the
high protein-greaves-meal treatment contained bacterial
species that belonged to the orders Clostridiales,
Coriobacteriales, and especially members of the order
Fusobacteriales [32]. Fusobacteriales have been implicated
to play a role in many different inflammatory processes, in-
cluding colonic inflammation [33-35]. Therefore, it could
be hypothesised that the diarrhoea observed in all dogs fed
the HPGM diet was probably associated with the amount
and/or quality of protein, which might change the intestinal
microbiota and their metabolic activity [9]. Alternatively, it
could be due to the lower levels of carbohydrates that enter
the large intestine, which lead to the abundance of bacteria
belonging to the order of Fusobacteriales [32].
In the present study, the high levels of greaves-meal (the
high protein diet) led to a decrease in total VFAs that were
mainly attributable to decreases in acetic and propionic
acids (Table 2). In contrast, the concentration of faecal
valeric acid increased for the HPGM diet. It has been
shown in previous studies that there are differences be-
tween protein sources in terms of fermentation end prod-
ucts [44], which result in higher proportions of valeric and
acetic acids in the canine colon arising from the fermenta-
tion of undigested proteins [45]. Acetic acid is produced
and excreted by the fermentation activities of acetic acid
producing bacteria (e.g., Acetobacter, B. subtilis) [46]. It
could be hypothesized that the decrease in faecal acetic acid
found in our study for the HPGM diet could be associated
with: a) a lower amount of acetic acid bacteria present in
the hindgut due to reduced levels of carbohydrate entering
the large intestine/colon; or b) it could be due to the high
amounts of greaves-meal entering the large intestine. It
could also be a combination of both a) and b).
Table 2 Canine faecal volatile fatty acid and calprotectin concentrations (n = 3 faecal samples for each variable per diet
period) of 5 dogs
Fecal variable Baseline (DC) DC1 HPGM 2 HCS 3 Kruskal-Wallis
p-value
Mixed model
p-value
Total VFA, mM 196 [165–221] A 195 [165–239] A 137 [75.0–192] B 176 [152.3–198] A 0.01 < 0.01
Acetic acid, mM 118 [90.0–135] A 118.9 [93.9–144] A 71.0 [47.8–105] B 96.9 [83.5–111] A,B < 0.01 < 0.01
Propionic acid, mM 49.3 [45.3–55.9] A 51.1 [33.5–63.8] A 25.2 [7.1–31.5] B 21.1 [14.0–29.9] A 0.02 < 0.01
Butyric acid, mM 21.3 [14.8–27.8] A 21.3 [14.8–27.8] A 16.8 [9.0–23.6] A 21.1 [14.0–29.9] A 0.10 0.08
Valeric acid, mM 0.4 [0.0–0.5] B 0.4 [0.0–0.8] B 9.8 [0.0–15.3] A 0.6 [0.4–6.6] B < 0.01 < 0.01
BCFA, mM 8.1 [6.8–12.1] A,B 8.3 [5.6–12.4] A,B 13.1 [2.2–18.9] A 8.2 [5.5–12.2] B 0.10 0.02
Calprotectin, μg/g 4.6 [2.9–7.5] B 3.0 [2.9–20.6] B 25.0 [12.0–113.4] A 8.8 [5.7–22.9]A,B 0.01 < 0.01*
*The ANOVA p-value was calculated for this variable due to lack of measurement points.
1DC: dry commercial diet.
2HPGM: high-protein greaves-meal diet.
3HCS: high-carbohydrate starch based diet.
Values are expressed as medians and ranges [min–max]. For each variable, diets not sharing a common superscript (A, B) are significantly different at p < 0.05 and
are marked in bold.
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(p = 0.02) in dogs fed the HPGM diet. It is generally
known that BCFAs are formed by the metabolism of
branched-chain amino acids such as valine, leucine, and
isoleucine following the breakdown of polypeptides
[47,48]. Consequently, the increase in faecal BCFAs
measured for the HPGM diet might be simply due to
the large amounts of protein entering the hindgut. An
increase in the concentration of BCFAs in stools has also
been reported in humans who were fed a diet containing
supplemental dietary protein based on whey, casein, and
lactalbumin [1].
Calprotectin was increased in the faeces of dogs fed
the HPGM diet (Table 2) and it was also positively cor-
related with the concentration of faecal valeric acid. In
human medical studies, calprotectin is reported to be a
sensitive but nonspecific biomarker of intestinal inflam-
mation [19,20] as the calprotectin parameter is not sen-
sitive enough for the definitive differentiation between
underlying intestinal diseases [49-51]. Calprotectin also
has bacteriostatic and fungistatic properties [21,22] that
have been suggested to protect the intestinal epithelium
against infection, thus contributing to the innate im-
munity of the host. Increased concentrations of faecal
calprotectin were detected in patients with Crohn’s dis-
ease [20,51], ulcerative colitis [49,50], and colorectal can-
cer [52]. Recently, the development and analytical
validation of a species-specific laboratory method for the
measurement of canine calprotectin in faeces for faecal
calprotectin has been published [31]. In our study, in-
creases in faecal canine calprotectin concentrations, oc-
curred only when dogs were fed the HPGM diet. This
increase also correlated positively with faecal valeric acid
levels. Interestingly, the faecal samples from dogs fed the
greaves-meal diet had a high preponderance of
Fusobacteriales bacteria [32]: an order of bacteria thathas been suspected to play a pathogenic role in human
intestinal inflammation [34-36]. Therefore, one could
hypothesize that Fusobacteria could produce branched
VFAs and valeric acid from protein break-down prod-
ucts [53]. Moreover, some Fusobacteria could act as
pathogens, which may cause intestinal inflammation that
would result in increased faecal calprotectin levels.
Therefore, valerate and calprotectin would be expected
to be correlated. However, further investigation is
needed to assess the possible role of Fusobacteriales
spp., and increased quantities of bacterially-derived fae-
cal valeric acid and faecal calprotectin in cases of canine
intestinal inflammation.Conclusions
Feeding a high protein diet with a high content of
greaves-meal to dogs led to diarrhoea in all the dogs of
our study. Intestinal metabolic (VFA profiles, ammonia,
and pH) and inflammatory (faecal calprotectin) parame-
ters for the HPGM diet differed from those of the HCS
or the DC diet. We conclude that the HPGM could have
mediated the following alternative scenarios: HPGM
caused high concentrations of protein to enter the hind-
gut, HPGM caused lower quantities of maize starch to
enter the hindgut, or a combination of both of these.
Any of these alternative mechanisms could lead to diar-
rhoea mediated by changes in the intestinal microbiota
and their metabolic activity. Such changes could possibly
lead to intestinal mucosal inflammation.Methods
Animals and diets
This study is the hitherto unreported part of a previously
published study [32] and was designed as a crossover
study. Five adult intact male Beagle dogsa (age: 5 years;
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according to European Union guidelines in indoor-pens
(dimension 3.3-6.9 m2) at the Experimental Animal Unit
of Helsinki University, Finland. The periods included a
baseline, the three treatment diets with washout periods.
Over the whole study, each dog received all the three di-
ets separated by washout but in different sequence from
one another. All dogs entered the baseline period at the
same time, followed by a different sequence of dietary
treatments and washout periods, which were crossed-
over as the study progressed (Table 3). The experimental
protocol was approved by the local Ethics Committee
for Animal Use and Care in Helsinki, Finland (Animal
Experiment Board, Regional State Administrative
Agency for Southern Finland, license ESLH-2008-04002/
Ym-23). Dogs were exposed to artificial light from 7–16.
The environmental temperature indoors was maintained
within a range of 15-24°C. The Beagles were considered
to be large-framed but not obese as based on visual
inspection.
All dogs received a dry commercial dietb (DC diet
comprising: crude protein 264 g/kg; starch, 277 g/kg), a
high-protein greaves-meal diet (HPGM diet comprising:
crude protein, 609 g/kg; starch, 54 g/kg), or a high-
carbohydrate starch based diet (HCS diet comprising:
crude protein, 194 g/kg; starch, 438 g/kg) as previously
published [32]. In addition to being one of the treat-
ments, the DC was used as the baseline diet and also as
the washout diet. Water was provided freely for the dur-
ation of the study.
Sample collection and handling
Fresh naturally-passed faecal samples were collected im-
mediately after defecation on the last three consecutive
days of every dietary treatment period for every dog.
Each treatment period counted sequentially from d 1 at
the beginning of the study baseline as the study
progressed to d 129 when the study treatments and sam-
pling ended (Table 3). Thus, the baseline period [Base-
line (DC)] on d 10–12, during the diet periods on d
15–17, and for the washout periods on d 22–24. For ex-
ample, the sampling time points in the feeding sequenceTable 3 The feeding sequence of the HPGM, HCS, and DC die
Dog Baseline (DC) Diet (D
1 DC diet DC1 HPGM
2 DC diet HPGM WO
3 DC diet HC WO
4 DC diet DC HCS
5 DC diet HCS WO
1DC: dry commercial (DC) diet.
2HPGM: high-protein greaves-meal diet.
3WO: washout period with the DC diet.
4HCS: high-carbohydrate starch based diet.for dog 2 (Table 3) were d 10–12 was the end of feeding
the baseline DC diet, d 29–31 was the end of feeding the
HPGM diet, d 57–59 was the end of first washout period
with the DC diet, d 78–80 was the end of HCS diet, d
106–108 was the end of second washout period with the
DC diet, and d 127–129 was the end of DC diet period.
Samples were thoroughly homogenized and faecal pH
was measured immediately after collection. Several 1-g
aliquots were then placed in preweighed sterile Sarstedt
faecal collection tubesc and frozen at −20°C for further
analyses of ammonia, dry matter, and VFAs. A sub-
sample was frozen at −80°C for the measurement of fae-
cal canine calprotectin.
For ammonia measurement, 1-g faecal samples were
pretreated by thorough mixing with 3 mL of 1 mol/L
HClO4 before freezing at −20°C. Faecal samples frozen
at −80°C were shipped on dry ice to the Gastrointestinal
Laboratory at Texas A&M University, USA for further
analyses of faecal canine calprotectin concentrations.
Clinical parameters
Body weight, food intake, and faecal consistency scores
were determined daily, as described previously [54].
Dogs were weighed once a week in the morning, before
feeding. For food intake assessment, the amount of food
allocated to each dog was calculated according to the in-
dividual energy requirements for each dog before enter-
ing the study. The amount of food given in grams was
weighed before it was given to each dog. Food weighing
after feeding was not needed as all the dogs ate every-
thing at every feeding point.
Fecal parameters
Faecal dry matter, pH, ammonia, VFA profiles, and ca-
nine calprotectin concentrations were measured in all
faecal samples. Faecal dry matter was determined by
overnight oven-drying of each sample at 103°C, as previ-
ously described [7]. Faecal pH was measured by using a
digital pH-meterd, as previously described [7,55]. In
order to ensure accuracy, the means of 3 replicate mea-
surements were calculated and entered into the data
analysis. Faecal ammonia concentrations were measuredts over six feeding periods
C, HPGM, and HCS) and washout periods (WO)
2 WO3 HCS4 WO
HCS WO DC
DC HPGM WO
WO HPGM WO
HPGM WO DC
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kite adapted for an automated chemistry analyzerf,
according to the manufacturer’s instructions.
The faecal VFA profiles, had determinations of
propionic acid, acetic acid, butyric acid, valeric acid, and
BCFA (isobutyric and isovaleric acid) and were mea-
sured, using a modified version of previously described
protocols [7,57] as follows: 0.5 g of faeces were mixed
with 4.25 mL of deionized water and 250 μL of a
premade solution of an internal standardg, the mixture
was then vortexed for 4 min, centrifuged at 5000 × g at
+4°C for 15 min, followed by centrifugation of 1 mL of
the supernatant at 10 000 × g at +4°C for 10 min. The
clear supernatant was then filtered into a 1.5-mL crimp
vial by using a syringe filterh. For measuring VFA con-
centrations, 1 μL of the filtrate was used for gas chroma-
tography with a flame ionization detectori.
Faecal calprotectin concentrations were determined at
the Gastrointestinal Laboratory at Texas A&M Univer-
sity. The faecal samples for all dogs (n = 5) for
calprotectin determinations were collected on the last
three consecutive days at the end of each dietary period
then pooled and thoroughly mixed. A previously devel-
oped and analytically validated in-house radioimmuno-
assay was used [31].Data handling and statistical analyses
Data are presented as medians and ranges for the mini-
mum and maximum and were analyzed by Excel and
JMP 7.0. The data of samples taken for the last three
consecutive days at the end of each diet period were
assessed for all parameters analysed, except faecal
calprotectin concentration. For each dog, the means of
food intake, body weight, and faecal consistency score,
faecal dry matter, pH, ammonia, and VFAs for three days
were calculated and each parameter entered as a single
datum. The faecal calprotectin concentrations represent
one pooled sample of three consecutive days (one faecal
sample per day) at the end of each diet period. The sig-
nificance of the dietary effect was determined, using a
mixed-effect model that included the parameters dog,
dog X diet interaction, and the time nested under the
diet as random effects. The non-parametric Kruskal-
Wallis test was used for evaluating the differences
among the diet treatments. Pair-wise Spearman correl-
ation coefficients were calculated for all parameters mea-
sured. Unless otherwise stated, the p-values reported
refer to the mixed-effect model. Significance was set at
below 0.05 for all statistical analyses.Endnotes
aBeagle dogs, origin: Harlan-Winkelmann, Borchen,
Germany;bMastery Pro Adult Maintenance, Raili Pispa Oy,
Muurla, Finland;
cFaecal collection tube (101 × 16.5 mm; incl. spatula),
Sarstedt Oy, Vantaa, Finland;
dKnick pH-Meter 761 Calimatic, Knick Elektronische
Messgeräte GmbH & Co, KG, Berlin, Germany;
eAmmonia Assay Kit, Megazyme International Ireland
Ltd., Wicklow, Ireland;
fKONE Pro, Thermo Fisher Scientific, Vantaa, Finland;
gInternal standard: 140 mM 4-methylvaleric acid in
formic acid, Helsinki, Finland;
hAcrodisc LC 13 mm with a 0.2-μm polyvinylidene
fluoride (PVDF) membrane, 4450 T, Pall Corporation,
Port Washington, New York, USA;
iAgilent 7890A and 7683, Agilent Technologies, Espoo,
Finland.
Abbreviation
HClO4: Perchloric acid.
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